These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20222806)

  • 1. Retroviral vector performance in defined chromosomal Loci of modular packaging cell lines.
    Gama-Norton L; Herrmann S; Schucht R; Coroadinha AS; Löw R; Alves PM; Bartholomae CC; Schmidt M; Baum C; Schambach A; Hauser H; Wirth D
    Hum Gene Ther; 2010 Aug; 21(8):979-91. PubMed ID: 20222806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new generation of retroviral producer cells: predictable and stable virus production by Flp-mediated site-specific integration of retroviral vectors.
    Schucht R; Coroadinha AS; Zanta-Boussif MA; Verhoeyen E; Carrondo MJ; Hauser H; Wirth D
    Mol Ther; 2006 Aug; 14(2):285-92. PubMed ID: 16697259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of retroviral vector design in defined chromosomal loci by Flp-mediated cassette replacement.
    Verhoeyen E; Hauser H; Wirth D
    Hum Gene Ther; 2001 May; 12(8):933-44. PubMed ID: 11387058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: predictability and efficiency by transgene exchange.
    Coroadinha AS; Schucht R; Gama-Norton L; Wirth D; Hauser H; Carrondo MJ
    J Biotechnol; 2006 Jul; 124(2):457-68. PubMed ID: 16529836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated strategy for the production of therapeutic retroviral vectors.
    Carrondo M; Panet A; Wirth D; Coroadinha AS; Cruz P; Falk H; Schucht R; Dupont F; Geny-Fiamma C; Merten OW; Hauser H
    Hum Gene Ther; 2011 Mar; 22(3):370-9. PubMed ID: 21043806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disclosing the Parameters Leading to High Productivity of Retroviral Producer Cells Lines: Evaluating Random Versus Targeted Integration.
    Bandeira VS; Tomás HA; Alici E; Carrondo MJ; Coroadinha AS
    Hum Gene Ther Methods; 2017 Apr; 28(2):78-90. PubMed ID: 28301970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of retroviral vector components stoichiometry on packaging cell lines: effects on productivity and vector quality.
    Carrondo MJ; Merten OW; Haury M; Alves PM; Coroadinha AS
    Hum Gene Ther; 2008 Feb; 19(2):199-210. PubMed ID: 18092921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccinia viral/retroviral chimeric vectors.
    Falkner FG; Holzer GW
    Curr Gene Ther; 2004 Dec; 4(4):417-26. PubMed ID: 15578991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.
    Byun J; Kim SH; Kim JM; Yu SS; Robbins PD; Yim J; Kim S
    Gene Ther; 1996 Sep; 3(9):780-8. PubMed ID: 8875226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A heterologous system for assembly of retroviral gene vectors: intracellular budding in yeast?
    Tolmachov O
    Med Hypotheses; 2006; 67(4):807-9. PubMed ID: 16759811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroviral vectors produced in the cytoplasmic vaccinia virus system transduce intron-containing genes.
    Konetschny C; Holzer GW; Falkner FG
    J Virol; 2002 Feb; 76(3):1236-43. PubMed ID: 11773399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic reshuffling reconstitutes functional expression cassettes in retroviral vectors.
    Tabotta W; Klein D; Hohenadl C; Salmons B; Günzburg WH
    J Gene Med; 2001; 3(5):418-26. PubMed ID: 11601755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a retroviral vector production system with the minimum possibility of a homologous recombination.
    Yu SS; Han E; Hong Y; Lee JT; Kim S; Kim S
    Gene Ther; 2003 Apr; 10(8):706-11. PubMed ID: 12692599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus vectors as transcomplementing templates for the production of replication defective retroviral vectors.
    Ramsey WJ; Caplen NJ; Li Q; Higginbotham JN; Shah M; Blaese RM
    Biochem Biophys Res Commun; 1998 May; 246(3):912-9. PubMed ID: 9618311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Packaging cell line characteristics and optimizing retroviral vector titer: the National Gene Vector Laboratory experience.
    Reeves L; Smucker P; Cornetta K
    Hum Gene Ther; 2000 Oct; 11(15):2093-103. PubMed ID: 11044911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells.
    Fischer YH; Miletic H; Giroglou T; Litwak S; Stenzel W; Neumann H; von Laer D
    J Gene Med; 2007 May; 9(5):335-44. PubMed ID: 17474071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new PG13-based packaging cell line for stable production of clinical-grade self-inactivating gamma-retroviral vectors using targeted integration.
    Loew R; Meyer Y; Kuehlcke K; Gama-Norton L; Wirth D; Hauser H; Stein S; Grez M; Thornhill S; Thrasher A; Baum C; Schambach A
    Gene Ther; 2010 Feb; 17(2):272-80. PubMed ID: 19865181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of retroviral packaging cell lines by introducing the polyomavirus early region.
    Yoshimatsu T; Tamura M; Kuriyama S; Ikenaka K
    Hum Gene Ther; 1998 Jan; 9(2):161-72. PubMed ID: 9472776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application: improved safety and high titer.
    Sheridan PL; Bodner M; Lynn A; Phuong TK; DePolo NJ; de la Vega DJ; O'Dea J; Nguyen K; McCormack JE; Driver DA; Townsend K; Ibañez CE; Sajjadi NC; Greengard JS; Moore MD; Respess J; Chang SM; Dubensky TW; Jolly DJ; Sauter SL
    Mol Ther; 2000 Sep; 2(3):262-75. PubMed ID: 10985957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.